SonoThera Newsroom.

Press Releases

July 31, 2023

SonoThera featured in the Wall Street Journal’s Future of Everything story on using ultrasound and microbubbles to enable therapeutic delivery to challenging organs

June 27, 2023

SonoThera™ Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer

May 15, 2023

SonoThera™ Announces Research Collaboration with Janssen Pharmaceuticals, Inc. to Accelerate Development of Ultrasound-Guided Nonviral Gene Therapy Platform

May 11, 2023

SonoThera™ to Present Preclinical Data on Use of Its Ultrasound-Guided Gene Therapy Platform at the 2023 ASGCT Annual Meeting

April 13, 2023

Bracco Imaging S.p.A. Announces a New Agreement with SonoThera™ To Explore the Emerging Field of Ultrasound-Guided Nonviral Gene Therapy

February 27, 2023

SonoThera™ Receives Exclusive Licensing of GE HealthCare’s Optison® and Sonazoid® Microbubble Products for use with its Ultrasound-guided Gene Therapy Platform

December 12, 2022

Lantheus Grants Rights for the Use of its Microbubbles to SonoThera for its Ultrasound-Guided Nonviral Gene Therapy Platform

December 5, 2022

SonoThera™ Completes $60.75M Series A Funding for Ultrasound-Guided, Nonviral Gene Therapy Platform Development

Media Inquiries

For media inquiries please reach out to media@sonothera.com.